Sangamo Therapeutics Inc. (SGMO)
0.72
0.02 (3.05%)
At close: Apr 10, 2025, 3:59 PM
0.71
-1.57%
After-hours: Apr 10, 2025, 07:53 PM EDT
Sangamo Therapeutics Revenue
Sangamo Therapeutics reported an annual revenue of $57.8M, reflecting a -67.2% growth. For the quarter ending December 31, 2024, Sangamo Therapeutics generated $7.55M in revenue.
Revenue (ttm)
$57.8M
Revenue Growth
-67.2%
Price / Sales Ratio
3.56
Revenue / Employee
$315.85K
Employees
183
Market Cap
162.65M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 57.8M | -67.20% |
Dec 31, 2023 | 176.23M | +58.34% |
Dec 31, 2022 | 111.3M | +0.54% |
Dec 31, 2021 | 110.7M | -6.34% |
Dec 31, 2020 | 118.19M | n/a |